The Asia Pacific drug delivery systems market is expected to reach US$ 441,337.0 Mn in 2027 from US$ 212,012.7 Mn in 2018. The market is estimated to grow with a CAGR of 8.6% from 2019-2027.
The growth of the market is driven by the factors such as, rapid technological advancements in diabetes care devices and increasing rate of obesity. However, the market is likely to slower down its growth due to the increasing reuse of pen needles in the region.
Obesity is one of the major problem and the biggest concern in all the countries across the region. Currently, more than one in two adults and nearly one in six children are obese. Obesity is one of the major issues that affects people of all ages and incomes globally. Overweight and obesity is the abnormal or excessive fat accumulation in the body leading to impaired health. According to the MoHFW, Government of India, in India is approx. 60 million adults with diabetes (7.8% of the population), of which more than 30 million are undiagnosed or untreated anticipated in 2015. Thus, there is higher increasing risk of developing complications and premature mortality. Obesity plays a major role in increasing diabetes among the population across the region. Physical activity is important to maintain the blood glucose level. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes, cardiovascular disease (CVD), chronic respiratory illnesses, and diet-related cancers. According the data of National Health and Nutrition Examination Survey, in 2015-2016, the obesity rate between the youth of the age group between 2 to 19 is 18.5%. The rate varies among different age groups, with rates rising along with age. While overall obesity rates remain higher than they were a generation ago.
Lack of exercise, unhealthy diet, and rapid growth in the obese population is expected to increase the susceptibility of diabetes among population in the region.
China is expected to lead the market in the Asia Pacific region owing to the technological advancements in medical device industry and rising focus on diagnosis and treatment of chronic diseases among the adults and the elderly population. Moreover, emergence of local players and rising number of product approvals in the country is expected to support the growth of drug delivery systems market in China. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
Rest of Asia Pacific Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
ASIA PACIFIC DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Product
- Oral
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-solid Oral Drugs
- Transmucosal
- Pulmonary Drug Delivery
- In-metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Buccal Drug Delivery
- Sublingual Drug Delivery
- Rectal Transmucosal Drug delivery
- Vaginal Transmucosal Drug Delivery
- Pulmonary Drug Delivery
- Injectable
- Conventional Injection Devices
- Self-Injection Devices
- Needle Free Injectors
- Pen Injectors
- Wearable Injectors
- Topical
- Semi-solid Topical Drug Delivery Formulations
- Liquid Topical Drug Delivery Formulations
- Solid Topical Drug Delivery Formulations
- Transdermal Patches
- Transdermal Gels
- Others
- Implantable
- Active Implantable
- Passive Implantable
- Ocular
- Eye Drops & Sprays
- Gels & Ointments
- Ocular Inserts
- Drug Coated Contact Lenses
By Application
- Hospital & Clinics
- Home Care Settings
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geography
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- BD
- 3M
- Novo Nordisk A/S
- BD
- Novo Nordisk A/S
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Route of Administration, Distribution Channel, and Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Asia Pacific Drug Delivery Systems Market – Key Takeaways
3. Asia Pacific Drug Delivery Systems Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Asia Pacific Drug Delivery Systems Market – By Route Of Administration
3.2.2 Asia Pacific Drug Delivery Systems Market – By Application
3.2.3 Asia Pacific Drug Delivery Systems Market – By Distribution Channel
3.2.4 Asia Pacific Drug Delivery Systems Market – By Country
3.3 Pest Analysis
4. Asia Pacific Drug Delivery Systems Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rapid Technological Advancements in Diabetes Care Devices
4.1.2 Increasing Rate of Obesity
4.2 Key Market Restraints
4.2.1 Increasing Reuse Of Pen Needles
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism In Developing Countries
4.4 Future Trends
4.4.1 Adoption Of Advanced Technology
4.5 Impact Analysis
5. Drug Delivery Systems Market – Asia Pacific Analysis
5.1 Asia Pacific Drug Delivery Systems Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.2.1 BD
5.2.2 3M
5.2.3 Glaxosmithkline Plc.
5.2.4 Novartis Ag
6. Asia Pacific Drug Delivery Systems Market Analysis – By Route Of Administration
6.1 Overview
6.2 Asia Pacific Drug Delivery Systems Market By Route Of Administration, 2018 & 2027 (%)
6.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
6.3.1 Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.2 Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.3 Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.4 Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.4.1 Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.5 Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.6 Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.7 Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.3.8 Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.4 Oral Drug Delivery Market
6.4.1 Overview
6.4.2 Oral Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.4.3 Solid Oral Drugs Market
6.4.3.1 Overview
6.4.3.2 Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
6.4.3.3 Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
6.4.4 Liquid Oral Drugs Market
6.4.4.1 Overview
6.4.4.2 Liquid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
6.4.4.3 Liquid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
6.4.5 Semi-Solid Oral Drugs Market
6.4.5.1 Overview
6.4.5.2 Semi-Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
6.4.5.3 Semi-Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
6.5 Transmucosal Drug Delivery Market
6.5.1 Overview
6.5.2 Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5.3 Pulmonary Drug Delivery Market
6.5.3.1 Overview
6.5.3.2 Pulmonary Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5.3.3 Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
6.5.3.4 In-Metered Dose Inhalers Market
6.5.3.4.1 Overview
6.5.3.4.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.5 Dry Powder Inhalers Market
6.5.3.5.1 Overview
6.5.3.5.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.6 Nebulizers Market
6.5.3.6.1 Overview
6.5.3.6.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Nasal Drug Delivery Market
6.5.4.1 Overview
6.5.4.2 Nasal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5.4.3 Nasal Spray Market
6.5.4.3.1 Overview
6.5.4.3.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.4 Nasal Drops Market
6.5.4.4.1 Overview
6.5.4.4.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.5 Nasal Gel Market
6.5.4.5.1 Overview
6.5.4.5.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Buccal Drug Delivery Market
6.5.5.1 Overview
6.5.5.2 Buccal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5.6 Sublingual Drug Delivery Market
6.5.6.1 Overview
6.5.6.2 Sublingual Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5.7 Rectal Transmucosal Drug Delivery Market
6.5.7.1 Overview
6.5.7.2 Rectal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5.8 Vaginal Transmucosal Drug Delivery Market
6.5.8.1 Overview
6.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.6 Topical Drug Delivery Market
6.6.1 Overview
6.6.2 Topical Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.6.3 Semi-Solid Topical Drug Delivery Formulations Market
6.6.3.1 Overview
6.6.3.2 Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
6.6.4 Liquid Topical Drug Delivery Formulations Market
6.6.4.1 Overview
6.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
6.6.5 Solid Topical Drug Delivery Formulations Market
6.6.5.1 Overview
6.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
6.6.6 Transdermal Patches Market
6.6.6.1 Overview
6.6.6.2 Transdermal Patches Market Revenue And Forecast To 2027 (US$ Mn)
6.6.7 Transdermal Gels Market
6.6.7.1 Overview
6.6.7.2 Transdermal Gels Market Revenue And Forecast To 2027 (US$ Mn)
6.6.8 Others Market
6.6.8.1 Overview
6.6.8.2 Others Market Revenue And Forecast To 2027 (US$ Mn)
6.7 Injectable Drug Delivery Market
6.7.1 Overview
6.7.2 Injectable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.7.3 Conventional Injection Devices Market
6.7.3.1 Overview
6.7.3.2 Conventional Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
6.7.4 Self-Injection Devices Market
6.7.4.1 Overview
6.7.4.2 Self-Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
6.7.4.3 Needle Free Injectors Market
6.7.4.3.1 Overview
6.7.4.3.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.4 Pen Injectors Market
6.7.4.4.1 Overview
6.7.4.4.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.5 Wearable Injectors Market
6.7.4.5.1 Overview
6.7.4.5.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Implantable Drug Delivery Market
6.8.1 Overview
6.8.2 Implantable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.8.3 Active Implantable Market
6.8.3.1 Overview
6.8.3.2 Active Implantable Market Revenue And Forecast To 2027 (US$ Mn)
6.8.4 Passive Implantable Market
6.8.4.1 Overview
6.8.4.2 Passive Implantable Market Revenue And Forecast To 2027 (US$ Mn)
6.9 Ocular Drug Delivery Market
6.9.1 Overview
6.9.2 Ocular Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.9.3 Eye Drops And Sprays Market
6.9.3.1 Overview
6.9.3.2 Eye Drops And Sprays Market Revenue And Forecast To 2027 (US$ Mn)
6.9.4 Gels & Ointments Market
6.9.4.1 Overview
6.9.4.2 Gels & Ointments Market Revenue And Forecast To 2027 (US$ Mn)
6.9.5 Ocular Inserts Market
6.9.5.1 Overview
6.9.5.2 Ocular Inserts Market Revenue And Forecast To 2027 (US$ Mn)
6.9.6 Drug Coated Contact Lens Market
6.9.6.1 Overview
6.9.6.2 Drug Coated Contact Lens Market Revenue And Forecast To 2027 (US$ Mn)
7. Asia Pacific Drug Delivery Systems Market Analysis – By Application
7.1 Overview
7.2 Asia Pacific Endodontic Devices Market Share By Application 2018 & 2027 (%)
7.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
7.4 Homecare Settings Market
7.4.1 Overview
7.4.2 Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
7.5 Hospitals & Clinics Market
7.5.1 Overview
7.5.2 Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Others Market Revenue And Forecasts To 2027 (US$ Mn)
8. Asia Pacific Drug Delivery Systems Market Analysis – By Distribution Channel
8.1 Overview
8.2 Asia Pacific Endodontic Devices Market Share By Distribution Channel 2018 & 2027 (%)
8.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
8.4 Homecare Settings Market
8.4.1 Overview
8.4.2 Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
8.5 Hospital Pharmacies Market
8.5.1 Overview
8.5.2 Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
8.6 Retail Pharmacies Market
8.6.1 Overview
8.6.2 Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
8.7 Online Pharmacies Market
8.7.1 Overview
8.7.2 Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
9. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027
9.1 Overview
9.1.1 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.2 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.2.1 Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.2 Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.3 Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.4 Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.4.1 Asia Pacific Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.2.5 Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.6 Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.7 Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.2.8 Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.4 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
9.1.5 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)
9.1.6 China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.7 China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.7.1 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.7.1.1 China Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.2 China Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.3 China Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.4 China Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.5 China Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.6 China Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.7 China Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.8 China Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.1.9 China Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.2 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.7.3 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
9.1.8 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.9 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.9.1 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.9.1.1 Japan Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.2 Japan Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.3 Japan Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.4 Japan Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.5 Japan Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.6 Japan Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.7 Japan Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.8 Japan Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.9 Japan Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.9.3 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
9.1.10 India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.11 India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
9.1.11.1 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.11.1.1 India Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.2 India Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.3 India Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.4 India Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.5 India Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.6 India Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.7 India Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.8 India Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.9 India Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.2 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.11.3 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
10. Drug Delivery Systems Market – Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies done by the companies in the Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic developments
10.5.1 Overview
11. Drug Delivery Systems Market–Key Company Profiles
11.1 3M
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 BD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novo Nordisk A/S
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bausch Health Companies Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BAxter International, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Boehringer Ingelheim International GmbH
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Novartis AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 GlaxoSmithKline plc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Terumo Corporation
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product portfolio
11.10.5 SWOT ANALYSIS
11.10.6 KEY DEVELOPMENTS
11.11 Johnson & Johnson Services, Inc.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 Swot Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
13. Glossary of Terms, Drug delivery systems market
13.1 Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Primary Research
LIST OF TABLES
Table 1. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 2. Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 3. Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 4. Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 5. Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 6. Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 7. Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 10. Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 11. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 12. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 13. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 14. Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 15. Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 16. Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 17. Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 18. Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 19. Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 20. Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 21. Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 22. Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 23. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 24. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 25. China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 26. China Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 27. China Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 28. China Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 29. China Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 30. China Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 31. China Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 32. China Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 33. China Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 34. China Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 35. China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 36. China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 37. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 38. Japan Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 39. Japan Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 40. Japan Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 41. Japan Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 42. Japan Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 43. Japan Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 44. Japan Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 45. Japan Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 46. Japan Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 47. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 48. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 49. India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 50. India Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 51. India Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 52. India Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 53. India Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 54. India Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 55. India Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 56. India Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 57. India Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 58. India Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 59. India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 60. India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 61. Organic Developments Done By Companies
Table 62. Inorganic developments done by Companies
LIST OF FIGURES
Figure 1. China Drug Delivery Systems Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. Asia Pacific Drug Delivery Systems Market By Route Of Administration, Market Share (%), 2018
Figure 3. Asia Pacific Drug Delivery Systems Market By Application, Market Share (%), 2018
Figure 4. Asia Pacific Drug Delivery Systems Market By Distribution Channel, Market Share (%), 2018
Figure 5. Drug Delivery Systems Market Segmentation
Figure 6. Asia Pacific Pest Analysis
Figure 7. Drug Delivery Systems Market Impact Analysis Of Drivers & Restraints
Figure 8. Asia Pacific Drug Delivery Systems Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 9. Global Drug Delivery Systems Market – Medical Device, 2017
Figure 10. Global Drug Delivery Systems Market – Pharmaceuticals, 2017
Figure 11. Asia Pacific Drug Delivery Systems Market, By Route Of Administration 2018 & 2027 (%)
Figure 12. Oral Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Transmucosal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. In-Metered Dose Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Dry Powder Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Nasal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Nasal Spray Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Nasal Spray Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Nasal Gel Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. Buccal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Sublingual Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Rectal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Vaginal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Topical Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Liquid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Transdermal Patches Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 30. Transdermal Gels Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. Injectable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. Conventional Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 34. Self-Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 35. Needle Free Injectors Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 36. Pen Injectors Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 37. Wearable Injectors Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 38. Implantable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 39. Active Implantable Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 40. Passive Implantable Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 41. Ocular Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 42. Eye Drops And Spray Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 43. Gels & Ointments Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 44. Ocular Inserts Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 45. Drug Coated Contact Lens Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 46. Asia Pacific Endodontic Device Market Share By Application 2018 & 2027 (%)
Figure 47. Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 48. Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 49. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 50. Asia Pacific Endodontic Device Market Share By Distribution Channel 2018 & 2027 (%)
Figure 51. Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 52. Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 53. Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 54. Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 55. Asia Pacific Drug Delivery Systems Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 56. Asia Pacific Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 57. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)
Figure 58. China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. Comparative Company Analysis
Figure 62. Growth Strategies done by the companies in the Market, (%)
The List of Companies
- BD
- 3M
- Novo Nordisk A/S
- BD
- Novo Nordisk A/S
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Drug Delivery Systems Market
Oct 2019
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Oct 2019
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Oct 2019
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
Oct 2019
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography
Oct 2019
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Oct 2019
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Get Free Sample For